Clinical study of topotecan and cisplatin as first line chemotherapy in epithelial ovarian cancer / 中华妇产科杂志

ABSTRACT

0.05).(4) ToxicityGrade Ⅲ-Ⅳ myelosuppression was 60%(18/30)in Tp group,26%(8/31)in TC group and 30%(10/33)in PC group.The TP regimen had the greatest hematologic toxicity(P0.05). Conclusions As first line chemotherapy in epithelial ovarian cancer,TP regimen comparable to the standard chemotherapy regimen.